Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In a 3-day-old neonatal murine model of influenza viral infection, intranasal treatment with Lacticaseibacillus rhamnosus GG (LGG) prior to influenza virus infection significantly enhanced survival rates coupled with downregulation of an antimicrobial gene for cathelicidin-related antimicrobial peptide (CRAMP).
see also:
Viral respiratory tract Infections
…